SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Preventive Visit — Marcus Aurelius

PatientMarcus Aurelius
Date of birth1973-04-25
IdentifiersMRN HR-AC004-SYN; SSN (made up) 000-04-1213
Document date2026-07-28
AuthorOctavia Ashworth-Nnamdi, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Periodic adult preventive visit. [S]

History of Present Illness

Mr. Aurelius is a 53-year-old man with reflux esophagitis diagnosed ten weeks ago, on omeprazole, chronic insomnia in cognitive behavioral therapy, and long-standing use of an opium-containing herbal paste, who comes for the preventive visit booked at intake. The COVID-19 illness three weeks ago settled in five days without antiviral treatment; the cough has gone and his energy is back. He took no extra remedy while ill and used no cough syrup. He finished the eight-week omeprazole course two weeks ago and has taken it on demand twice since, each time after a late dinner; otherwise he has no reflux symptoms, and he eats his main meal earlier. He has taken the paste on alternate nights since early June; he has decided that from tonight he will take a smaller amount on only two nights a week. He has never had colorectal cancer screening or a pneumococcal or shingles vaccine. [S]

ElementDetail
VisitPeriodic adult preventive visit, age 53
COVID-19Resolved after five days; no antiviral
RefluxEight-week omeprazole course finished two weeks ago; on demand twice since
MoodPHQ-2 1

Health risk assessment. Completed by the patient on a tablet in the waiting room and reviewed with him by Dr. Ashworth-Nnamdi. [S]

DomainFinding
Self-rated healthGood, better than in the spring
PsychosocialHeavy responsibility at work; delegates more after the evening meal; trusted colleagues
Substance useAUDIT-C 2; the herbal paste on alternate nights, about two nights a week from today; no other drugs
TobaccoNever
Physical activityWalks and rides most days, more than 150 minutes a week
NutritionTwo meals a day, the main meal now early in the evening; bread, vegetables, fish and olive oil
SleepAbout six hours, improving with CBT-I
SafetyWears a seat belt; no firearms in his quarters; naloxone at the bedside
Sexual healthNo concerns
Activities of daily livingIndependent

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever; energy back; weight up 1.4 kg since intake
EyesNegativeNo change in vision; uses reading glasses
Ears, nose, mouth, and throatNegativeNo hearing loss or sore throat
CardiovascularNegativeNo chest pain, palpitations or ankle swelling
RespiratoryNegativeNo cough or breathlessness
GastrointestinalPositiveHeartburn twice in two weeks after late dinners, eased by omeprazole; no pain after meals, difficulty swallowing, or blood in the stool; soft stools on the laxative
GenitourinaryNegativeNo urinary symptoms
MusculoskeletalNegativeNo joint pain
IntegumentaryNegativeNo rash or changing moles
EndocrineNegativeNo thirst or frequent urination
PsychiatricNegativeMood steady; PHQ-2 1

11 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Opium-containing compounded herbal paste (an electuary of honey, many herbs and poppy, from an overseas supplier; not prescribed and not regulated, so its morphine content is unknown), about a pea-sized amount (roughly 0.5 g) by mouth at bedtime most nights for about six years, and now and then in the morning before a long dayAbout 0.5 g at bedtime most nights; occasionally a second amount in the morningOral route2020-05-01 to 2026-06-06completedS
Calcium carbonate 500 mg chewable tablet, one or two tablets as needed for heartburn, no more than six a day, until the endoscopyOne or two tablets as needed, at least four hours apart; no more than six a dayOral route2026-05-12 to 2026-05-19completedS
Polyethylene glycol 3350 powder, 17 g dissolved in a glass of water by mouth once daily as needed for constipation17 g once daily as neededOral route2026-05-12activeS
Naloxone 4 mg nasal spray, one spray into one nostril for suspected opioid overdose, repeated in 2 to 3 minutes in the other nostril if there is no response; call 911One spray for suspected overdose; repeat every 2 to 3 minutes if neededNasal route2026-05-12activeS
Omeprazole 20 mg delayed-release capsule, one capsule by mouth 30 to 60 minutes before breakfast for eight weeks, for erosive esophagitisOne capsule each morning before breakfast for eight weeksOral route2026-05-19 to 2026-07-14completedS
Omeprazole 20 mg delayed-release capsule, one capsule by mouth before breakfast on days after heartburn returns (on-demand therapy after the eight-week course)One capsule on a day with heartburn; no more than one a dayOral route2026-07-14activeS
Opium-containing compounded herbal paste (unregulated, strength unknown), about 0.5 g by mouth at bedtime on alternate nights, a reduction he chose and made himselfAbout 0.5 g at bedtime every other nightOral route2026-06-06 to 2026-07-28completedS
Opium-containing compounded herbal paste (unregulated, strength unknown), a smaller amount, about 0.3 g, by mouth at bedtime on about two nights a week, a further reduction he choseAbout 0.3 g at bedtime on about two nights a weekOral route2026-07-28activeS
Acetaminophen 500 mg oral tablet, one or two tablets by mouth every six hours as needed for fever or aches, no more than 3 g a dayOne or two tablets every six hours as needed; no more than six a dayOral route2026-07-07 to 2026-07-28completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-07-28Body height172cmS
2026-07-28Body weight64.4kgS
2026-07-28Body mass index (BMI) [Ratio]21.8kg/m2S
2026-07-28Systolic blood pressure118mm[Hg]S
2026-07-28Diastolic blood pressure76mm[Hg]S
2026-07-28Heart rate70/minS
2026-07-28Respiratory rate14/minS
2026-07-28Body temperature36.6CelS
2026-07-28Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-07-28Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S
2026-07-28Total score [AUDIT-C]2{score}S

Physical Exam

Vital signs recorded on 2026-07-28; see the Vital Signs section. [S]

SystemFinding
ConstitutionalWell; weight 64.4 kg, BMI 21.8; blood pressure 118/76, pulse 70
SkinNo suspicious moles
NeckThyroid normal; no lymph nodes
CardiovascularRegular rhythm; no murmur
RespiratoryClear
AbdomenSoft and non-tender; no mass
PsychiatricEngaged and calm

Problems

ProblemClinical statusVerificationCodeProvenance
Burning and pressing pain in the upper abdomen and lower chest after meals, for more than a year and worse over three months, with poor appetite, waking at night with pain and a sour taste, and a 3 kg weight loss; not brought on by exertion; normal ECG; cardiac and peptic causes to be excludedresolvedconfirmed R10.13S — Synthetic presenting concern at the index visit, superseded by the diagnosis at endoscopy; its pattern echoes the stomach and chest complaints and the pain with food that Dio describes (D).
Gastroesophageal reflux disease with erosive esophagitis, Los Angeles grade B, and a 2 cm sliding hiatal hernia; Helicobacter pylori negative on biopsy; coronary disease excluded by CT coronary angiography; synthetic modern diagnosis for his documented stomach and chest complaintsactiveconfirmed K21.00S — Synthetic modern diagnosis; the cause of his real complaints is unknown and no historical diagnosis is made.
Daily use of an unregulated opium-containing herbal remedy for about six years, for stomach pain and sleep; opioid use disorder criteria not met (one DSM-5-TR criterion, restlessness and poor sleep when he stopped it); expected physiological dependence; constipation and possibly slowed gastric emptying from the opioidactiveconfirmed F11.90S — Synthetic modern finding anchored to the theriac he took (D); no opioid use disorder or addiction is attributed to him (the claim is disputed, R).
Chronic insomnia disorder for more than a year, with waking from night pain and trouble returning to sleep; Insomnia Severity Index 17 (moderate)activeconfirmed G47.00S — Synthetic modern finding anchored to Galen's account of his sleeplessness without the poppy juice (D, possible).
Sustained strain of command: leads a large organization through a long field assignment far from home, with long days and little restactiveconfirmed Z56.6S — Synthetic work strain anchored to his documented years on campaign (D).
Constipation from the opioid in his remedy: hard stools every two or three daysactiveconfirmed K59.03S — Synthetic finding at intake.
COVID-19, mild (rapid antigen test positive), without breathlessness or low oxygen; antiviral treatment offered and declined; resolvedresolvedconfirmed U07.1S — Synthetic intercurrent illness; not a claim about the Antonine Plague or about any illness in his lifetime.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Blood pressure screeningCompleted today118/76 mmHg
Depression screeningCompleted todayPHQ-2 score 1
Unhealthy alcohol use screeningCompleted todayAUDIT-C score 2
Tobacco useCompleted todayNever smoked
Lipid screening and statin assessmentUp to dateLipids at intake (LDL 133 mg/dL, lipoprotein(a) 38 nmol/L); coronary calcium score 0 and no plaque on CT; low ten-year risk; no statin
Diabetes screeningUp to dateA1c 5.4% at intake
Colorectal cancer screeningOrderedNever screened; colonoscopy ordered, with extra bowel preparation because of the opioid
Prostate cancer screeningNot indicatedAn individual decision from 55; to be discussed then
Lung cancer screeningNot indicatedNever smoked
HIV screeningCompleted todayOnce for adults 15 to 65; sent today
Hepatitis C screeningCompleted todayOnce for adults 18 to 79; sent today
Hepatitis B screeningCompleted todayOnce for all adults; sent today before the first vaccine dose
Pneumococcal vaccineCompleted todayPCV20, one dose, at 50 or older
Zoster vaccineCompleted todayRecombinant zoster vaccine, dose 1 of 2
Hepatitis B vaccineCompleted todayDose 1 of 2 today, dose 2 at the next visit
Tetanus, diphtheria, and pertussisUp to dateTdap about six years ago by his report; next in about four years
Influenza vaccineDueIn the autumn
COVID-19 vaccineDueDue about three months after the infection three weeks ago

Immunizations given today: Pneumococcal conjugate vaccine, 20-valent (PCV20), single dose for an adult aged 50 or older; Recombinant zoster vaccine (RZV), dose 1 of 2; Hepatitis B vaccine (HepB-CpG), dose 1 of 2 [S]

Guideline basis: Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Colorectal Cancer: Screening (2021); Adult Immunization Schedule by Age (2026)

Follow-up: Fifteen-week review as planned, with PHQ-9, GAD-7, the Insomnia Severity Index and the second hepatitis B dose. HIV and hepatitis results by phone. Colonoscopy as ordered. Next preventive visit in one year. Next scheduled visit 2026-08-25: fifteen-week review after the eight-week omeprazole course: on-demand therapy, sleep, the remedy, and mood. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 20 minutes, with his consent. He wants full treatment for any condition from which he could recover to his present life and work, and does not want his life prolonged by machines if he could not. He named a health care agent, recorded in the confidential part of the chart and not named here, and will write his wishes down in his own words. To be revisited yearly. [S]